SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Roudy who wrote (1645)3/22/1999 3:21:00 PM
From: Roudy  Read Replies (1) of 1762
 
(posting from Yahoo)salomon...reiterates...target $60

by: RU2L8 671 of 671"we expect idec to exceed their previous guidance of $48-$51mm in rituxan sales for 1q99. .......thus we believe hat $250mm rituxan sales for 99 are highly conservative....we would use any weakness as a buying opportunity." this analyst has been right on with idph.....sheis looking for eps of 1.05 1999//1.50 2000//2.50 in 2001...... hope this gives the board some updates.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News